enVVeno Medical
NVNO
26 hedge funds and large institutions have $17.3M invested in enVVeno Medical in 2024 Q2 according to their latest regulatory filings, with 4 funds opening new positions, 8 increasing their positions, 7 reducing their positions, and 8 closing their positions.
4,229% more call options, than puts
Call options by funds: $1.65M | Put options by funds: $38K
14% more repeat investments, than reductions
Existing positions increased: 8 | Existing positions reduced: 7
0.08% less ownership
Funds ownership: 0.78% → 0.71% (-0.08%)
13% less capital invested
Capital invested by funds: $19.8M → $17.3M (-$2.55M)
16% less funds holding
Funds holding: 31 → 26 (-5)
50% less first-time investments, than exits
New positions opened: 4 | Existing positions closed: 8
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
WIM
Westside Investment Management
Santa Monica,
California
|
+$175K |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
+$75.8K |
| 3 |
AMCA
Arthur M. Cohen & Associates
Northbrook,
Illinois
|
+$69.8K |
| 4 |
UBS Group
Zurich,
Switzerland
|
+$56K |
| 5 |
FA
Fermata Advisors
Sonoma,
California
|
+$38.6K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
VCIM
Velan Capital Investment Management
Alpharetta,
Georgia
|
-$937K |
| 2 |
Marshall Wace
London,
United Kingdom
|
-$218K |
| 3 |
Citadel Advisors
Miami,
Florida
|
-$192K |
| 4 |
Janney Montgomery Scott
Philadelphia,
Pennsylvania
|
-$186K |
| 5 |
Jane Street
New York
|
-$138K |
NVNO Hedge Fund Activity: Q2 2024 in Review
26 of the 6,924 institutional investors tracked by Wall St. Rank reported a position in enVVeno Medical (NVNO) for Q2 2024, worth a combined $17.3M — down 13% from $19.8M a quarter earlier.
Sellers outnumbered buyers: 8 funds closed out of NVNO and 4 opened new positions — a net loss of 4 holders — while 7 trimmed existing stakes and 8 added.
The largest buyer was Westside Investment Management, adding an estimated $175K. The largest seller was Velan Capital Investment Management, exiting entirely with an estimated $937K sold.
- 26 institutional investors held enVVeno Medical (NVNO) as of Q2 2024, down from 31 in Q1 2024.
- Funds reported $17.3M of enVVeno Medical stock for Q2 2024, down 13% quarter-over-quarter.
- 4 funds opened new enVVeno Medical positions in Q2 2024 and 8 closed out, a net change of -4 holders.
- The largest enVVeno Medical buyer in Q2 2024 was Westside Investment Management, an estimated $175K added.
- The largest enVVeno Medical seller in Q2 2024 was Velan Capital Investment Management, an estimated $937K sold.
Based on aggregated 13F filings for Q2 2024.